Pieter Stolk

1.6k total citations
59 papers, 1.1k citations indexed

About

Pieter Stolk is a scholar working on Economics and Econometrics, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Pieter Stolk has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Economics and Econometrics, 12 papers in Immunology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Pieter Stolk's work include Pharmaceutical Economics and Policy (21 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers) and Biosimilars and Bioanalytical Methods (12 papers). Pieter Stolk is often cited by papers focused on Pharmaceutical Economics and Policy (21 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers) and Biosimilars and Bioanalytical Methods (12 papers). Pieter Stolk collaborates with scholars based in Netherlands, United Kingdom and United States. Pieter Stolk's co-authors include A. Barneveld, P. René van Weeren, Jacintha M. Wilmink, Hubert G. M. Leufkens, Kevin Klein, Eibert R. Heerdink, F. N. van Mil, Daan J.A. Crommelin, Marie L. De Bruin and Hubert G.M. Leufkens and has published in prestigious journals such as Nature Reviews Drug Discovery, Journal of Clinical Epidemiology and Annals of Oncology.

In The Last Decade

Pieter Stolk

58 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pieter Stolk Netherlands 20 240 177 122 122 101 59 1.1k
Timo Sahi Finland 24 40 0.2× 50 0.3× 487 4.0× 6 0.0× 191 1.9× 47 2.9k
Stephanie Evans United Kingdom 21 40 0.2× 41 0.2× 105 0.9× 2 0.0× 72 0.7× 55 1.4k
Jinhee Lee South Korea 20 16 0.1× 94 0.5× 161 1.3× 3 0.0× 174 1.7× 56 1.6k
Orsolya Varga Hungary 16 34 0.1× 33 0.2× 34 0.3× 9 0.1× 134 1.3× 60 1.1k
David M. Brogan United States 20 110 0.5× 257 1.5× 688 5.6× 39 0.4× 105 1.5k
Nan Yang China 18 43 0.2× 110 0.6× 116 1.0× 82 0.8× 70 1.2k
Jack Wilkinson United Kingdom 26 26 0.1× 37 0.2× 135 1.1× 2 0.0× 413 4.1× 104 1.8k
Olga Scudiero Italy 29 29 0.1× 136 0.8× 215 1.8× 2 0.0× 104 1.0× 74 2.3k
Herbert Thijs Belgium 23 54 0.2× 66 0.4× 96 0.8× 83 0.8× 42 1.7k
R. B. Payne United Kingdom 24 20 0.1× 12 0.1× 253 2.1× 8 0.1× 99 1.0× 121 2.6k

Countries citing papers authored by Pieter Stolk

Since Specialization
Citations

This map shows the geographic impact of Pieter Stolk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter Stolk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter Stolk more than expected).

Fields of papers citing papers by Pieter Stolk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter Stolk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter Stolk. The network helps show where Pieter Stolk may publish in the future.

Co-authorship network of co-authors of Pieter Stolk

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter Stolk. A scholar is included among the top collaborators of Pieter Stolk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter Stolk. Pieter Stolk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Kevin, et al.. (2022). Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences?. Therapeutic Innovation & Regulatory Science. 56(2). 366–377. 9 indexed citations
2.
Boer, Casper de, Jelena Curcic, Vera J. M. Nies, et al.. (2021). Gait characteristics in preclinical Alzheimer’s disease: Preliminary results of the RADAR‐AD study. Alzheimer s & Dementia. 17(S5). 2 indexed citations
3.
Danhof, Meindert, Kevin Klein, Pieter Stolk, Murray Aitken, & Hubert G. M. Leufkens. (2018). The future of drug development: the paradigm shift towards systems therapeutics. Drug Discovery Today. 23(12). 1990–1995. 24 indexed citations
4.
Klein, Kevin & Pieter Stolk. (2018). Challenges and Opportunities for the Traceability of (Biological) Medicinal Products. Drug Safety. 41(10). 911–918. 20 indexed citations
5.
Liberti, Lawrence, Alasdair Breckenridge, Jarno Hoekman, et al.. (2017). Factors related to drug approvals: predictors of outcome?. Drug Discovery Today. 22(6). 937–946. 7 indexed citations
6.
Irving, Elaine, Katrien Oude Rengerink, Iris Goetz, et al.. (2016). Pragmatic trial design elements showed a different impact on trial interpretation and feasibility than explanatory elements. Journal of Clinical Epidemiology. 77. 95–100. 8 indexed citations
7.
Tafuri, Giovanni, Pieter Stolk, Francesco Trotta, et al.. (2013). How do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers’ views. Annals of Oncology. 25(1). 265–269. 33 indexed citations
8.
Shah, Vinod P., et al.. (2009). The pharmaceutical sciences in 2020—Report of a conference organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP). European Journal of Pharmaceutical Sciences. 38(5). 419–425. 3 indexed citations
9.
Stolk, Pieter, Patrick C. Souverein, Ingeborg Wilting, et al.. (2009). Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukotrienes and Essential Fatty Acids. 82(1). 9–14. 55 indexed citations
10.
Stolk, Pieter, et al.. (2009). No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study. Orphanet Journal of Rare Diseases. 4(1). 27–27. 17 indexed citations
11.
Ravera, Silvia, et al.. (2009). The use of driving impairing medicines: a European survey. European Journal of Clinical Pharmacology. 65(11). 1139–1147. 22 indexed citations
12.
Weeren, P. René van, et al.. (2007). Does equine veterinary medicine pay off? A survey of revenue in current practices in The Netherlands. Equine Veterinary Education. 19(5). 273–280. 4 indexed citations
13.
Stolk, Pieter, et al.. (2006). Medicamentos esenciales raros: los fármacos contra enfermedades raras como medicamentos esenciales. Bulletin of the World Health Organization. 84(9). 745–751. 1 indexed citations
14.
Stolk, Pieter, et al.. (2006). Between-country variation in the utilization of antihypertensive agents: guidelines and clinical practice. Journal of Human Hypertension. 20(12). 917–922. 21 indexed citations
15.
Stolk, Pieter, Maarten J. ten Berg, M. Hemels, & Thomas R. Einarson. (2003). Meta-Analysis of Placebo Rates in Major Depressive Disorder Trials. Annals of Pharmacotherapy. 37(12). 1891–1899. 42 indexed citations
16.
Stolk, Pieter, Toine C. G. Egberts, & Hubert G. M. Leufkens. (2002). Fate of abstracts presented at five International Conferences on Pharmacoepidemiology (ICPE): 1995–1999. Pharmacoepidemiology and Drug Safety. 11(2). 105–111. 22 indexed citations
17.
Wilmink, Jacintha M., H. Nederbragt, P. René van Weeren, Pieter Stolk, & A. Barneveld. (2001). Differences in wound contraction between horses and ponies: the in vitro contraction capacity of fibroblasts. Equine Veterinary Journal. 33(5). 499–505. 26 indexed citations
18.
Loon, C. J. M. van, M.C. de Waal Malefijt, Pieter Buma, et al.. (2000). Autologous morsellised bone grafting restores uncontained femoral bone defects in knee arthroplasty. Journal of Bone and Joint Surgery - British Volume. 82-B(3). 436–444. 13 indexed citations
19.
Stolk, Pieter, et al.. (1996). Total replacement of the metatarsophalangeal joint in the horse. Veterinary Quarterly. 18(sup2). 90–93. 1 indexed citations
20.
Gruys, E., et al.. (1994). [Neurodegenerative disorders of the central nervous system in horses].. PubMed. 119(19). 561–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timo Sahi Breakdown of academic impact, for papers by Stephanie Evans Breakdown of academic impact, for papers by Jinhee Lee Breakdown of academic impact, for papers by Orsolya Varga Breakdown of academic impact, for papers by David M. Brogan Breakdown of academic impact, for papers by Nan Yang Breakdown of academic impact, for papers by Jack Wilkinson Breakdown of academic impact, for papers by Olga Scudiero Breakdown of academic impact, for papers by Herbert Thijs Breakdown of academic impact, for papers by R. B. Payne
Rankless by CCL
2026